# Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

> **NCT05645744** · — · TERMINATED · sponsor: **Mustang Bio** · enrollment: 3 (actual)

## Conditions studied

- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Chronic Lymphocytic Leukemia in Relapse
- Small Lymphocytic Lymphoma, Relapsed
- Waldenstrom's Macroglobulinemia Recurrent
- Follicular B-cell Non-Hodgkin's Lymphoma
- B-cell Lymphoma Refractory
- Mantle Cell Lymphoma Recurrent
- Hairy Cell Leukemia
- Diffuse Large B Cell Lymphoma
- Waldenstrom's Macroglobulinemia Refractory
- Mantle Cell Lymphoma Refractory

## Interventions

- **BIOLOGICAL:** Prior MB-102 CAR-T cell investigational product.
- **BIOLOGICAL:** Prior MB-106 CAR-T cell investigational product.

## Key facts

- **NCT ID:** NCT05645744
- **Lead sponsor:** Mustang Bio
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-29
- **Primary completion:** 2024-04-12
- **Final completion:** 2024-04-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Business Reasons
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645744, "Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05645744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*